Juan Rodés

Juan Rodés's AcademicInfluence.com Rankings

Juan Rodés

Philosophy

#4676

World Rank

#7286

Historical Rank

Logic

#2084

World Rank

#2994

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Juan Rodés's Degrees

Doctorate Medicine University of Barcelona

Why Is Juan Rodés Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Juan Rodés's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. (2001) (3999)
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. (1999) (1508)
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model (2002) (1132)
Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis (2002) (921)
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. (1996) (835)
Management of cirrhosis and ascites. (2004) (754)
EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. (1999) (715)
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. (2006) (649)
Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis (1995) (590)
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. (1990) (577)
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study (2002) (541)
Hemodynamic response to pharmacological treatment of portal hypertension and long‐term prognosis of cirrhosis (2003) (513)
Hepatitis C virus kinetics during and immediately after liver transplantation (2002) (511)
Prognostic significance of hepatic encephalopathy in patients with cirrhosis. (1999) (506)
Angiotensin II induces contraction and proliferation of human hepatic stellate cells. (2000) (464)
Prognostic value of early measurements of portal pressure in acute variceal bleeding. (1999) (460)
Oxford Textbook of Clinical Hepatology (1999) (455)
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. (2002) (440)
Bacterial translocation of enteric organisms in patients with cirrhosis. (2001) (433)
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. (1999) (428)
Portal hypertension and variceal bleeding: An AASLD single topic symposium (1998) (421)
Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. (1998) (419)
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems (1998) (378)
Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. (2000) (366)
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. (2008) (358)
Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. (2003) (332)
MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation (2005) (326)
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. (2000) (323)
Prognostic importance of the cause of renal failure in patients with cirrhosis. (2011) (315)
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. (2003) (312)
Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. (1997) (288)
Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion (1998) (287)
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. (2003) (282)
A prognostic model for predicting survival in cirrhosis with ascites. (2001) (268)
Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. (1992) (266)
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation (2002) (265)
The role of ultrasonography and automatic‐needle biopsy in outpatient percutaneous liver biopsy (1996) (264)
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis (1991) (263)
Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short‐term prognosis (2001) (261)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats (2007) (261)
Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. (2004) (255)
Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. (2005) (255)
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis (2002) (254)
Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. (1991) (252)
Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. (2004) (248)
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. (2003) (239)
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial (2000) (229)
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension (1982) (226)
Hyperintense globus pallidus on T1‐weighted MRI in cirrhotic patients is associated with severity of liver failure (1993) (226)
Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation (2000) (225)
Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. (2002) (219)
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. (2004) (215)
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA (2006) (214)
Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients (1980) (212)
Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. (2005) (212)
Osteoporosis and Bone Mineral Metabolism Disorders in Cirrhotic Patients Referred for Orthotopic Liver Transplantation (1997) (209)
Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage (1984) (208)
TIPS is a useful long‐term derivative therapy for patients with Budd‐Chiari syndrome uncontrolled by medical therapy (2002) (207)
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites: Relationship between the diuretic response and the activity of the renin-aldosterone system (1983) (205)
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). (2003) (204)
Circulating levels of endothelin in cirrhosis. (1993) (196)
Hepatopulmonary syndrome in candidates for liver transplantation. (2001) (195)
Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. (1995) (189)
Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. (1989) (187)
Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. (2001) (185)
Textbook of hepatology : from basic science to clinical practice (2007) (183)
Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients. (1985) (174)
Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia–reperfusion (2010) (168)
Bone Disease After Liver Transplantation: A Long-Term Prospective Study of Bone Mass Changes, Hormonal Status and Histomorphometric Characteristics (2001) (163)
Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. (2005) (161)
Ecstasy: a common cause of severe acute hepatotoxicity. (1998) (161)
Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis (1996) (155)
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. (1996) (155)
Bacterial infections in liver disease. (1997) (152)
Diabetes mellitus after liver transplantation: prevalence and predictive factors. (1996) (152)
Increased cerebrovascular resistance in cirrhotic patients with ascites (1998) (152)
Hemodynamic evaluation of the patient with portal hypertension. (1986) (151)
Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. (1989) (149)
Effect of angiotensin‐ll blockade on systemic and hepatic haemodynamics and on the renin‐angiotensin‐aldosterone system in cirrhosis with ascites (1981) (146)
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. (1993) (142)
Effects of blood volume restitution following a portal hypertensive–related bleeding in anesthetized cirrhotic rats (2001) (142)
Prognostic value of spontaneous hyponatremia in cirrhosis with ascites (1976) (141)
Current knowledge on oxidative stress in hepatic ischemia/reperfusion (2013) (141)
Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. (1995) (138)
Cyclooxygenase‐derived products modulate the increased intrahepatic resistance of cirrhotic rat livers (2003) (137)
Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. (1996) (136)
Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. (2003) (136)
Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. (1990) (127)
Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. (1985) (126)
Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis. (1993) (125)
Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. (2003) (125)
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. (1997) (125)
Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. (1984) (123)
The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. (1998) (123)
Effects of low‐sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis (1994) (123)
Propranolol for the prevention of first esophageal variceal hemorrhage: A lifetime commitment? (2001) (123)
Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: Prognostic value of resistive index (1994) (121)
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis (1996) (121)
Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. (1997) (118)
Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. (1996) (117)
Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. (2002) (116)
Extracorporeal Albumin Dialysis: A Procedure for Prolonged Relief of Intractable Pruritus in Patients with Primary Biliary Cirrhosis (2004) (110)
Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A (2001) (109)
Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. (1992) (109)
Role of a research ethics committee in follow-up and publication of results (2003) (108)
Time profile of the haemodynamic effects of terlipressin in portal hypertension. (1997) (108)
Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites. (1983) (107)
Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. (1997) (105)
Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors (2005) (104)
Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. (1981) (103)
Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. (1985) (102)
Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. (1995) (100)
5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes. (2002) (100)
Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: Influence of the extent of portal‐systemic shunting (1989) (98)
Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis. (1996) (98)
Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. (2001) (97)
Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis. (1977) (97)
Pathogenesis of ascites in cirrhosis. (1987) (96)
Portal hypertension in primary biliary cirrhosis. Relationship with histological features. (1987) (96)
Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. (1988) (94)
Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. (1998) (93)
Human hepatic stellate cells show features of antigen‐presenting cells and stimulate lymphocyte proliferation (2003) (93)
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. (1998) (91)
Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. (1997) (91)
Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension. (1990) (91)
Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). (1986) (91)
Beneficial Effect of Angiotensin-Blocking Agents on Graft Fibrosis in Hepatitis C Recurrence after Liver Transplantation (2004) (89)
Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. (1980) (89)
Predictive factors of in‐hospital CNS complications following liver transplantation (1994) (88)
Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis (2003) (88)
Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites (1994) (88)
Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis (2003) (87)
Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation. (1991) (87)
Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism. (1990) (87)
Carbon tetrachloride–induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: Effect of S‐adenosylmethionine treatment (1995) (84)
Bacterial infections in cirrhosis (2004) (82)
Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon (1999) (81)
Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. (1994) (80)
Ascites after liver transplantation (2000) (79)
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. (1983) (78)
Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics. (1992) (77)
Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects. (1999) (77)
Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. (2000) (77)
Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. (2003) (76)
Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. (1997) (75)
Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis (2003) (74)
Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis. (1987) (73)
Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats: effect of zinc administration. (1992) (73)
Bone fractures in liver transplant patients. (1994) (73)
Effect of venovenous bypass on perioperative renal function in liver transplantation: Results of a randomized, controlled trial (1996) (73)
Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. (1995) (73)
Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy. (1997) (72)
Liver transplantation for acute liver failure: analysis of applicability. (1993) (70)
Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. (1993) (70)
Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. (1998) (70)
On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease (1993) (70)
Renal failure associated with demeclocycline in cirrhosis. (1977) (70)
Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. (2005) (70)
Type‐1 hepatorenal syndrome associated with infections in cirrhosis: Natural history, outcome of kidney function, and survival (2014) (69)
Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. (1986) (68)
Nosocomial transmission of HCV in the liver unit of a tertiary care center (2005) (67)
Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. (2003) (67)
Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver. (1998) (67)
A rational approach to the treatment of ascites (1975) (67)
In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L‐type voltage‐operated calcium channels (2001) (66)
Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: Comparison with therapeutic paracentesis (1995) (66)
Sex hormone receptors in hepatocellular carcinoma. Is there a rationale for hormonal treatment? (1993) (66)
The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than in those with varices. (1997) (65)
Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. (1992) (65)
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites (1983) (65)
Pathophysiology of ascites and functional renal failure in cirrhosis. (1988) (64)
Sodium fluoride prevents bone loss in primary biliary cirrhosis. (1992) (64)
Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases. (1999) (63)
Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics. (2005) (62)
Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats. (1989) (61)
Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. (1993) (61)
Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. (1992) (61)
Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. (2001) (61)
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. (2004) (60)
Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. (1996) (59)
Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal‐hypertensive gastropathy (1994) (59)
Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome. (1996) (58)
The role of vasoactive mediators in portal hypertension. (1995) (58)
Risk factors for hepatocellular carcinoma in catalonia, spain (1990) (58)
Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. (1996) (57)
Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. (1999) (57)
Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis. (1993) (56)
Clinical types and drug therapy of renal impairment in cirrhosis (1975) (56)
Vertebral fractures and osteopenia in chronic alcoholic patients (1995) (56)
Epidemiology of primary biliary cirrhosis. (2008) (55)
Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. (1980) (55)
Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. (1997) (54)
Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin. (2004) (54)
Liver transplantation in patients with Caroli's disease and recurrent cholangitis (1997) (54)
Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients (1996) (54)
High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV‐1b–related cirrhosis (2001) (53)
Contraction of human hepatic stellate cells activated in culture: a role for voltage-operated calcium channels. (1998) (53)
Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. (1997) (53)
Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. (1995) (53)
Anti‐gp210 antibody mirrors disease severity in primary biliary cirrhosis (2007) (53)
Daily Norfloxacin Is More Effective Than Weekly Rufloxacin in Prevention of Spontaneous Bacterial Peritonitis Recurrence (2002) (52)
Effects of somatostatin on renal function in cirrhosis. (1992) (50)
Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. (1997) (50)
Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. (1994) (50)
Fulminant hepatic failure (1997) (50)
Hepatorenal syndrome. (2003) (49)
Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy (1994) (49)
Portal hypertension in acute liver failure. (1992) (48)
Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. (2003) (48)
Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury (2008) (48)
Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients (1999) (48)
Diagnosis, treatment and prevention of spontaneous bacterial peritonitis. (2000) (47)
Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention. (1995) (47)
Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume. (1995) (46)
Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis (1995) (46)
Bacterial infections in liver cirrhosis. (1999) (45)
Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis. (1984) (45)
Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome. (2006) (45)
Natural history of primary biliary cirrhosis. (2003) (45)
Acute liver failure due to non-Hodgkin's lymphoma. (1993) (45)
Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels (1995) (44)
Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells. (1997) (44)
Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial. (1987) (44)
Are Angiotensin II Receptor Antagonists Useful Strategies in Steatotic and Nonsteatotic Livers in Conditions of Partial Hepatectomy under Ischemia-Reperfusion? (2009) (43)
Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. (1996) (43)
Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis. (1996) (43)
Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites. (2003) (42)
Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis. (1987) (42)
Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: Relationship with the activity of neurohormonal systems (1997) (42)
Management of patients with cirrhosis and ascites. (1986) (41)
Cyclosporin A increases the biochemical markers of bone remodeling in primary biliary cirrhosis. (1994) (41)
Surgical resection and survival in Western patients with hepatocellular carcinoma. (1992) (40)
Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications. (1997) (40)
Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis (2001) (40)
Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats. (2005) (40)
Recombinant α2c-interferon therapy in fulminant viral hepatitis (1987) (40)
Existence of a platelet‐adhesion defect in patients with cirrhosis independent of hematocrit: Studies under flow conditions (1996) (40)
Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection. (1995) (39)
Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation (2010) (39)
Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients (2002) (39)
Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis (2005) (39)
Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics. (1984) (39)
Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention. (1999) (39)
Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats. (2000) (38)
Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration. (1994) (38)
Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats (2008) (38)
Hepatitis G virus infection in chronic liver disease (1998) (38)
Gastric microcirculatory changes of Portal‐hypertensive rats can be attenuated by long‐term Estrogen‐progestagen treatment (1994) (37)
Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation. (1996) (37)
Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation (2001) (37)
The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning. (2015) (37)
Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients. (1998) (36)
p27Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma (2003) (36)
Diabetes mellitus in patients with liver cirrhosis. (1994) (34)
Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis. (2000) (34)
[82] RANDOMIZED, COMPARATIVE STUDY OF TERLIPRESSIN AND ALBUMIN VS ALBUMIN ALONE IN PATIENTS WITH CIRRHOSIS AND HEPATORENAL SYNDROME (2007) (34)
Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation. (1988) (33)
Atrial natriuretic peptide antagonizes endothelin‐induced calcium increase and cell contraction in cultured human hepatic stellate cells (1999) (32)
Therapeutic Targets in Liver Transplantation: Angiotensin II in Nonsteatotic Grafts and Angiotensin‐(1–7) in Steatotic Grafts (2009) (32)
Natural history of chronic persistent hepatitis B. Relationship between hepatitis B virus replication and the course of the disease. (1985) (31)
Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy. (1988) (31)
Internal initiation of translation efficiency in different hepatitis C genotypes isolated from interferon treated patients (1999) (30)
Bile-duct hamartomas presenting as multiple focal lesions on hepatic ultrasonography. (1992) (30)
Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. (1992) (30)
Hyperglucagonemia and hyperkinetic circulation after portocaval shunt in the rat. (1987) (30)
Carbohydrate-deficient transferrin as a marker of alcohol consumption in male patients with liver disease. (1997) (29)
Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury. (2009) (29)
Measurement of hepatic blood flow, hepatic extraction and intrinsic clearance of indocyanine green in patients with cirrhosis. Comparison of a non-invasive pharmacokinetic method with measurements using hepatic vein catheterization (1991) (29)
Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis. (1997) (28)
Effects of somatostatin in patients with portal hypertension. (1988) (28)
High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites. (2004) (28)
Human myofibroblastic hepatic stellate cells express Ca(2+)-activated K(+) channels that modulate the effects of endothelin-1 and nitric oxide. (2001) (28)
Doses of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. (1991) (27)
Adiponectin and resistin protect steatotic livers undergoing transplantation. (2013) (27)
nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. (1994) (27)
Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites. (1989) (27)
Human hepatic stellate cells secrete adrenomedullin: potential autocrine factor in the regulation of cell contractility. (2001) (27)
Prolonged cholestasis after acute paraquat poisoning through skin absorption (2000) (27)
Anemia Worsens Hyperdynamic Circulation of Patients with Cirrhosis and Portal Hypertension (1997) (27)
Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection. (1993) (26)
Retinol-Binding Protein 4 and Peroxisome Proliferator-Activated Receptor-γ in Steatotic Liver Transplantation (2011) (26)
Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. (1992) (26)
Influence of zinc intake on hepatic lipid peroxidation and metallothioneins in alcoholic rats: relationship to collagen synthesis. (1995) (26)
Primary Biliary Cirrhosis Specific Antinuclear Antibodies in Patients from Spain (2004) (26)
Treatment of HCV infection in patients with advanced cirrhosis (2004) (25)
Hepatitis G virus infection in fulminant hepatic failure (1997) (25)
Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity (1991) (25)
New approaches in the pharmacologic treatment of portal hypertension. (1993) (25)
Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites. (2004) (25)
Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin‐like growth factor‐I to University of Wisconsin solution (2010) (24)
Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B. (1995) (24)
Cyclic adenosine 3′,5′‐monophosphate in rat steatotic liver transplantation (2011) (23)
Urinary excretion of urodilatin in patients with cirrhosis (1996) (23)
Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis. (1992) (23)
Tauroursodeoxycholic Acid Affects PPARγ and TLR4 in Steatotic Liver Transplantation (2012) (23)
For the EASL Panel of Experts on hepatocellular carcinoma (2001) (23)
Cyclosporine-associated mutism in liver transplant patients (1996) (22)
Increased plasma levels of neuropeptide Y in hepatorenal syndrome. (2002) (22)
Liver transplantation and quality of life. (2000) (22)
Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV. (2000) (22)
The effects of glucose and lipids in steatotic and non‐steatotic livers in conditions of partial hepatectomy under ischaemia‐reperfusion (2014) (22)
Molecular Evidence of Mother-to-Infant Transmission of Hepatitis G Virus among Women without Known Risk Factors for Parenteral Infections (1999) (22)
Recombinant alpha 2c-interferon therapy in fulminant viral hepatitis. (1987) (22)
Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factors. (1998) (22)
Characterization and evolution of NS5A quasispecies of hepatitis C virus genotype 1b in patients with different stages of liver disease (2003) (21)
Anastrozole as neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer. (2004) (21)
Post-transfusional vs. sporadic non-A, non-B chronic hepatitis. A clinico-pathological and evolutive study. (2008) (21)
Pathophysiology, complications, and treatment of ascites. (1997) (21)
Rhodococcus equi infection after liver transplantation. (1996) (21)
Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction (2003) (21)
Circulatory effects of graded diversion of portal blood flow to the systemic circulation in rats: Role of nitric oxide (1997) (20)
Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis. (1991) (20)
S-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats. (2000) (20)
Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis. (1994) (20)
Matrix Metalloproteinase 2 in Reduced‐Size Liver Transplantation: Beyond the Matrix (2010) (20)
Recurrent liver involvement in heatstroke. (2008) (19)
Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels. (1988) (18)
Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis. (1997) (18)
Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failure. (1988) (18)
Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis. (1994) (18)
Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C. (2000) (18)
Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. (1980) (18)
p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma. (2003) (18)
Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites (1998) (18)
Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B. (1988) (18)
Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion. (2014) (17)
Tumor size determines the long-term efficacy of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC) (1991) (17)
Ascites from cirrhotic patients induces angiogenesis through the phosphoinositide 3-kinase/Akt signaling pathway. (2005) (16)
Atrial natriuretic factor: reduced cardiac content in cirrhotic rats with ascites. (1986) (16)
[Hepatic angiosarcoma: a report of a case associated with treatment with arsenic salts and a review of the literature]. (1995) (16)
Session 8 ‒ Complications in the Medical Treatment of Portal Hypertension (2008) (15)
Sustained aquaretic effect of the V2‐AVP receptor antagonist, RWJ‐351647, in cirrhotic rats with ascites and water retention (2005) (15)
Longitudinal study of renal prostaglandin excretion in cirrhotic rats: relationship with the renin-aldosterone system. (1988) (15)
Familial Clustering of Hepatitis B Antigen: A Study in Relatives of Patients with Liver Diseases and Hepatitis B Antigenaemia (1974) (15)
Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal‐hypertensive rats (1994) (14)
Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats. (2007) (14)
ESOPHAGEAL VARICEAL BLEEDING CAUSED BY HYPOPLASIA OF THE PORTAL VEIN IN A PATIENT WITH THE KLIPPEL-TRENAUNAY SYNDROME (1998) (14)
The Effect of High‐Mobility Group Box 1 in Rat Steatotic and Nonsteatotic Liver Transplantation From Donors After Brain Death (2016) (14)
Increased plasma volume in two models of portal hypertension in the rat: cirrhosis of the liver and partial portal vein ligation. (1987) (14)
[Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men]. (2000) (14)
Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC) (2001) (13)
Duodenal variceal bleeding treated with a transjugular intrahepatic portosystemic shunt. (1995) (13)
The second year in Barcelona (2002) (13)
Exudative Ascites in the Course of Acute Type B Hepatitis (2007) (13)
Effects of terlipressin administration with and without albumin in hepatorenal syndrome (HRS). A phase II study (2002) (13)
[The applicability and diagnostic effectiveness of transjugular liver biopsy]. (1996) (12)
Hyperkinetic circulation and decreased sensitivity to vasoconstrictors following portacaval shunt in the rat. Effects of chronic nitric oxide inhibition. (1999) (12)
Mechanical pumping of portal blood to the liver: hemodynamic effects of a new experimental treatment for portal hypertension. (1996) (12)
Erratum: impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: Results of a European concerted action (Journal of Hepatology (1998) 29 (173-83)) (1998) (12)
[Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension]. (1997) (11)
[Prevalence of hepatocellular carcinoma in cirrhotic patients with with portosystemic shunt. Cohort analysis]. (1996) (11)
Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial. (1996) (11)
Treatment of ascites and renal failure in cirrhosis. (1989) (11)
Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion (2012) (11)
Portal hypertension. (1989) (11)
[Autoimmune hepatitis associated with thyroiditis and hypophysitis. A case report]. (2000) (11)
[De novo tumors in adult patients with hepatic transplant]. (1997) (11)
Urinary endothelin-like immunoreactivity in patients with cirrhosis. (1997) (11)
Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis. (1996) (10)
Pathogenesis of Renal Vasoconstriction in Cirrhosis (2007) (10)
Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee (2016) (10)
Spontaneous Bacterial Peritonitis: The Disease, Pathogenesis and Treatment (2000) (10)
In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin. (1999) (10)
[Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence]. (1996) (10)
Reduced doses of hepatitis B immunoglobulin protect against hepatitis B virus infection recurrence after liver transplantation. (2001) (10)
Pathogenesis and treatment of ascites (1996) (9)
Genetic evolution of hepatitis G virus in chronically infected individual patients. (1998) (9)
Efficacy of somatostatin and vasopressin in the control of acute variceal hemorrhage (1985) (9)
The effect of cortisol in rat steatotic and non-steatotic liver transplantation from brain-dead donors. (2017) (9)
675 Anastrozole is an effective neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer irrespective of cerbB2 status (2003) (9)
Metabolism of the Bromsulphalein in Dubin-Johnson syndrome (1972) (9)
Zinc administration improves gastric alcohol dehydrogenase activity and first-pass metabolism of ethanol in alcohol-fed rats. (1997) (9)
Clinical manifestations and therapy of hepatic encephalopathy. (1993) (8)
current concepts Management of Cirrhosis and Ascites (2004) (8)
Hepatorenal syndrome (2003) (8)
The HVPG-response to pharmacological treatment of portal hypertension predicts prognosis and the risk of developing complications of cirrhosis (2002) (8)
Effect of transjugular intrahepatic portosystemic shunt (TIPS) on renal function and vasoactive systems in hepatorenal syndrome (SHR) (1998) (8)
Influence of hepatitis C virus on hepatitis B virus infection (1990) (8)
Long-term follow-up of chronic NANB (C) hepatitis (1990) (8)
Influence of dietary zinc on hepatic collagen and prolyl hydroxylase activity in alcoholic rats. (1990) (8)
Duration and severity of the disease but not menopausal status are the main risk factors for osteoporosis in primary biliary cirrhosis (2002) (8)
Prostaglandins and renal function in cirrhosis. (1986) (7)
Spironolactone (Sp) decreases portal pressure in patients with compensated cirrhosis (1991) (7)
Therapy in liver diseases : the pathophysiological basis of therapy (1997) (7)
Clinical events following TIPS: Correlation with hemodynamic findings (1995) (7)
Rolling review: the treatment of major complications of cirrhosis. (1994) (7)
Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure. (1992) (7)
À La Carte Interferon for Hepatitis C? (2000) (7)
Treatment of ascites in patients with cirrhosis of the liver. (1987) (7)
Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration (1997) (7)
Other clinical studyNoninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis (1995) (7)
Familial spread of type-B hepatitis. (1973) (7)
Focal nodular hyperplasia in a young female. (1998) (6)
130 Pharmacological reduction of portal pressure and long term risk of first variceal bleeding in patients with cirrhosis (2003) (6)
Systemic, splanchnic and humoral changes after orthotopic liver transplantation (OLT) in cirrhosis (1991) (6)
Ascites and hepatorenal syndrome: pathogenesis and treatment strategies. (1998) (6)
Correspondence. Is the Concept of “Exudative” Ascites Useful? (1984) (6)
Neutrophil adhesion is impaired in the mesentery but not in the liver sinusoids of portal hypertensive rats. (2001) (6)
Impact of an intestinal decontamination (ID) program on the incidence of spontaneous bacterial peritonitis (SBP) and bacteremia (SB) in hospitalized cirrhotic patients (1991) (6)
Hyperhomocysteinemia in chronic alcoholism. Relationship to liver damage (2002) (6)
Portal pressure in patients with exudative ascites in the course of acute hepatitis B. (2008) (6)
Endogenous nitric oxide is involved in hemodynamics disturbances in portal hypertensive (PH) rats (1991) (5)
Effects of spontaneous bacterial peritonitis (SBP) on systemic and splanchnic hemodynamics in patients with cirrhosis (2001) (5)
Reversibility of hepatorenal syndrome (HRS) by the administration of terlipressin and albumin. A phase-II study (2000) (5)
Platelet cytosolic calcium concentration in patients with liver cirrhosis. Relationship with hepatic and systemic hemodynamics. (1997) (5)
The impact of cortisol in steatotic and non‐steatotic liver surgery (2017) (5)
Predictive factors of early graft function in human liver transplantation (1991) (5)
[Prolonged administration of hepatitis B hyperimmune gamma globulin in patients with liver transplantation in liver diseases caused by hepatitis B virus]. (1996) (5)
Impact of pretransplant treatment of hepatorenal syndrome (HRS) with vasopressin analogues on outcome after liver transplantation (LTX). A case-control study (2003) (5)
Letter: Family outbreak of hepatitis B. (1973) (5)
Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma. (1997) (5)
Lack of effect of pentoxifylline on portal pressure and hepatic haemodynamics in cirrhosis (1990) (5)
Hepatorenal syndrome and ascites--questions and answers. (1999) (5)
The molecular adsorbent recirculating system (MARS) improves systemic hemodynamics and hepatic encephalopathy in patients with severe alcoholic hepatitis (2002) (5)
Ascites and renal failure in primary liver cell carcinoma. (1975) (5)
Epidemiology of PBC in Europe: A ten year follow-up study (1989) (5)
Expected developments in hepatology. (2002) (5)
Reversal of portal blood flow after distal splenorenal shunt (DSRS). Relationship to hepatic encephalopathy and impaired liver function (1989) (4)
Gene expression profiling of renal dysfunction in rats with experimental cirrhosis. (2006) (4)
Malignant Histocytosis Presenting as a Fulminant Hepatic Disease (1983) (4)
Hepatorenal syndrome. (2005) (4)
Cirrhotic livers exhibit a hyperesponse to methoxamine. Role of nitric oxide and eicosanoids (2001) (4)
Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
Factors influencing histological progression of early primary biliary cirrhosis. Effect of ursodeoxycholic acid (2001) (4)
Increased alphafetoprotein levels in hepatocellular carcinoma: The relationship with tumor size determines its limited value in early detection (1989) (4)
Incidence and predictive factors of severe HCV recurrence after liver transplantation (1998) (4)
36 Pentoxifylline prevents small intestinal bacterial overgrowth (SIBO), bacterial translocation (BT) and spontaneous bacterial peritonitis (SBP) in experimental cirrhosis (2004) (4)
Normalization of portal pressure (PP) following end-to-side portacaval shunt (PCS) worsens systemic hemodynamic abnormalities in cirrhosis (1991) (4)
Digestive involvement in systemic autoimmune diseases (2015) (4)
Cross-reactivity between mycobacterium gordonae and PDC-E2, the major target of anti-mitochondrial antibody, is present in Spanish but not British patients with PBC (2001) (4)
Mechanism of the blunted renal response to atrial natiuretic factor (ANF) in cirrhotics with ascites, evidence against a role of impaired systemic hemodynamics (1989) (4)
Isosorbide 5-mononitrate (ISMN) increases plasma renin activity (PRA) and aldosterone (ALD) and impairs renal function in cirrhosis with ascites (1991) (4)
Temporal relationship between the decrease in arterial pressure and the onset of sodium retention in hypertensive rats with carbon tetrachloride induced cirrhosis (1989) (4)
Iatrogenic hepatitis (2001) (4)
The evolution of knowledge on the pathophysiology of portal hypertension. (1996) (3)
Effects of molsidomine. A long-acting venous dilator, on hepatic haemodynamics in patients with cirrhosis and portal hypertension (1989) (3)
The fourth year in Barcelona (2004) (3)
Family outbreak of hepatitis B. (1973) (3)
Interferon in chronic hepatitis C (1995) (3)
Perinatal transmission of hepatitis C virus from a mother without detectable antibodies to the virus. (1994) (3)
Transplantation in Journal of Hepatology (2003) (3)
Long-term ursodeoxycholic acid treatment delays progression of mild primary biliary cirrhosis (2001) (3)
The road to developing clinical trials: The Barcelona Liver Unit's experience and the dedication to the dream (2013) (3)
[Post-transfusional hepatitis following cardiac surgery. Incidence, clinical aspects and prognosis]. (1987) (3)
Diagnosis and therapy of hepatic encephalopathy. (1994) (3)
Molecular adsorbent recirculating system: a new procedure for relieving intractable pruritus in patients with primary biliary cirrhosis (2002) (3)
[Bioartificial liver support for acute liver failure. First case treated in Spain]. (2001) (3)
Portal-systemic shunting (PSS) influences hemodynamic abnormalities in bile duct ligated (BDL) rats (1991) (3)
Hyperdynamic circulation and renal dysfunction in cirrhosis with ascites are not due to a generalized arteriolar vasodilation (1991) (3)
Effect of radiocontrast agents on renal function in patients with cirrhosis and ascites (2002) (3)
Somatostatin is less effective decreasing portal pressure during acute variceal bleeding than in stable conditions (1998) (3)
A simple method for assessing timing of liver transplantation in primary biliary cirrhosis (PBC) (1991) (3)
Albumin versus dextran-70 IN cirrhotics with tense ascites treated with total paracentesis. Final results of a multicenter randomized comparative study (1990) (2)
Ascites, Hepatorenal Syndrome, and Spontaneous Bacterial Peritonitis (2010) (2)
Chronic hepatitis D in intravenous drug addicts and non-addicts. A comparative clinico-pathological study. (1988) (2)
Cyclical etidronate versus sodium fluoride for treatment of osteoporosis in primary biliary cirrhosis. Preliminary results after two years (2006) (2)
Spontaneous bacterial peritonitis (SBP) in acute liver failure (ALF): Incidence and characteristics (1991) (2)
Favorable effects of propranolol in patients with malfunctioning porto-caval or distal spleno-renal shunts (1989) (2)
Circadian variation of portal pressure in patients with cirrhosis. Relationship with variceal bleeding (1990) (2)
Spontaneous regression of hepatocellular carcinoma (1992) (2)
Propranolol in the prophylaxis of oesophageal variceal haemorrhage in patients with cirrhosis: A double-blind, multicenter controlled trial (1990) (2)
The association of isosorbide-5-mononitrate enhances the reduction in portal pressure caused by propranolol in patients with cirrhosis (1990) (2)
Effects of zinc administration on liver fibrogenesis and collagenolysis in rats induced to cirrhosis (1989) (2)
[Infectious complications associated with liver transplantation: analysis of 104 patients]. (2001) (2)
Alendronate versus etidronate for osteopenic patients with primary biliary cirrhosis: results after two years of treatment (2001) (2)
Neurogenic arthropathy of the foot and syringomyelia (1985) (2)
The third year in Barcelona (2003) (2)
Chapter 22 – Renal Dysfunction in Cirrhosis: Pathophysiology, Clinical Features and Therapy (2006) (2)
Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factors (1998) (2)
A prospective study of nosocomial transmission of hepatitis C virus (HCV) in the liver unit of a tertiary care center (2003) (2)
Diagnosis and evaluation of portal hypertension. (1988) (2)
Susceptibility to primary biliary cirrhosis. (1979) (2)
Evaluation of the portal hypertensive patient. (1989) (2)
Failure of acarbose in preventing bacterial translocation in experimental cirrhosis. (2003) (2)
Endothelin (ET) has natriuretic effect in conscious cirrhotic rats with ascites (1990) (2)
[Anterior mediastinal hematoma secondary to catheterization of the jugular vein]. (1988) (2)
4 Inhibition of VEGF receptor-2 (VEGFR-2) signaling prevents portal-systemic collateral (PSC) vessel formation in rats with portal hypertension (PH) (2004) (2)
144 INSULIN-LIKE GROWTH FACTOR AND EPIDERMAL GROWTH FACTOR TREATMENT: NEW APPROACHES TO PROTECTING STEATOTIC LIVERS AGAINST ISCHEMIA-REPERFUSION INJURY (2010) (2)
Norfloxacin prevents spontaneous bacterial peritonitis (SBP) in cirrhosis. Final results of a multicenter double-blind placebo controled study (1990) (2)
Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites. (1988) (2)
[Thrombocytopenic purpura and acute nephropathy associated with circulating immune complexes in hepatitis A virus infection]. (1993) (2)
Endoscopic measurement of variceal pressure (VP) in patients with cirrhosis. Correlation with the niec index (NI) and with the risk of variceal hemorrhage (1990) (2)
Hepatorenal syndrome (2001) (2)
Goodbye from Barcelona! (2004) (1)
Intracellular and exchangeable potassium in cirrhosis. Evidence against the occurrence of potassium depletion in cirrhosis with ascites. (1981) (1)
Perinatal transmission of HCV documented by specific PCR in a prospective study (1991) (1)
[Clinical research: from bench to bedside]. (2003) (1)
LActobacillus spp. strain LGG does not prevent small intestinal bacterial overgrowth (SIBO) and bacterial translocation (BT) in experimental cirrhosis (2001) (1)
The first year in Barcelona (2001) (1)
Hepatitis C: Who Should You Treat and How? (2002) (1)
[Non-alcoholic steatohepatitis]. (2003) (1)
The uses of error: iatrogenic hepatitis. (2001) (1)
21 The selective cyclooxygenase-2 inhibitor SC-236 reduces experimental liver fibrosis by inactivating kupffer cells and acting as a peroxisome proliferator-activated receptor gamma ligand (2004) (1)
The endogenous cannabinoid, anandamide, produces a specific and high vasodilator effect in mesenteric vessels of cirrhotic rats (2003) (1)
The experience of the Hospital Clinic of Barcelona: Integration Medical School-IDIBAPS- University Hospital (2007) (1)
The stage of chronic hepatitis C and the type of response to interferon therapy are not related with hepatitis C virus (HCV) genotype 1b quasispecies complexity (1998) (1)
FLUMACENIL EN LA VALORACION DEL GRADO DE ENCEFALOPATIA HEPATICA (1991) (1)
Protective effect of zinc on hepatic lipid peroxidation and fibrogenesis in CCL4-treated rats. A possible role for metallothioneins (1991) (1)
Effects of zinc on hepatic lipid peroxidation and liver fibrosis in carbon tetrachloride-treated rats (1990) (1)
Ciclosporin (CyA) in Primary Biliary Cirrhosis (PBC): A Multicentre, Double-blind, Placebo-controlled Long-term Therapeutic Study. The Study Design (1985) (1)
Miscellaneous I (1952) (1)
The blockade of the vascular effect of antidiuretic hormone (ADH) decreases arterial pressure in experimental cirrhosis with asches (1989) (1)
Improvement in systemic hemodynamics after albumin dialysis is associated with a decrease in vasoactive agents (2003) (1)
News from Spain (2004) (1)
Unusual amino acid heterogeneity within the HCV-1b NS5a region for patients with hepatocellular carcinoma (2000) (1)
Dietary n-3 polyunsaturated fatty acid supplementation: Lack of renal effect in cirrhosis with ascites (1991) (1)
Effects of S-adenosylmethicnine on liver fibrosis in rats (1991) (1)
[Usefulness of biological markers for the detection of alcoholism and the diagnosis of alcoholic liver disease]. (1988) (1)
History taking and examinationAscites (2007) (1)
Early HCV viral kinetics after liver transplantation (2001) (1)
Hyperglucagonism reduces the pressor response to angiotensin and vasopressin in portal hypertension (1990) (1)
Treatment of ascites in patients with cirrhosis of the liver (2004) (1)
Chromatographic pattern and biological activity of atrial natriuretic factor (ANF) in cirrhosis with ascites (1989) (1)
Experimental effects of zinc in liver and gut. (1997) (1)
[Factors responsible for renal sodium retention in hepatic cirrhosis with ascites]. (1975) (1)
Dipyridamole induces renal failure in cirrhosis with ascites (1990) (1)
Increased circulating levels of neuropeptide Y (NPY) in hepatorenalsyndrome (HRS). A possible role in the pathogenesis of renalvasoconstriction (2000) (1)
The Liver in Urogenital Diseases (2008) (1)
Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressure. (2000) (1)
Abstract papers presentedEndotoxin, platelet-activating factor and renal function in cirrhosis (1990) (1)
Lymphocyte beta-2 adrenoceptors (LAR-B2), plasma catecholamines and haemodynamic response to propranolol (PROP) in patients with cirrhosis and portal hypertension. (1989) (1)
Increased systemic production of carbon monoxide in patients with cirrhosis and ascites with and without spontaneous bacterial peritonitis (SBP) (2002) (1)
Hepatic gene expression of activated AKT normalizes portal pressure in experimental cirrhosis (2003) (1)
Genetic polymorphisms of alcohol metabolizing enzymes do not influence the development of alcoholic liver disease (2002) (1)
[The efficacy of excluding anti-HVC-positive donors by ELISA 2 in the prevention of posttransfusion hepatitis]. (1996) (1)
Effects of propranolol (Prop) and placebo (Pla) on oesophageal variceal pressure (OVP) in cirrhosis (1990) (1)
Propranolol effectively decreases portal pressure in patients with tips dysfunction (2001) (1)
196 Cannabinoid CB1 receptors are overexpressed in resistance mesenteric arteries of cirrhotic rats with ascites (2004) (1)
Bacterial infections in cirrhotic patients with transjugular intrahepatic portosystemic shunt (2002) (1)
The combined chronic administratton of propranolol (Prop) and isosorbide-5-mononitrate (Is-5-Mn) achieve greater beneficial effects than either drug alone (1989) (1)
The Jornal of Hepatology in the New Millennium (2000) (1)
Comparison of the effcts of propranolol (Prop) and placebo (Pla) on variceal pressure (VP) and hepatic venous pressure gradient (HVPG) in cirrhosis (1991) (1)
Different effects of protein and carbohydrate meals on splanchnic hemodynamics and portal pressure in patients with cirrhosis (1988) (1)
Antibiotics and renal tubular damage in cirrhosis (1983) (0)
Chapter 32. Ascites, Hepatorenal Syndrome, and Spontaneous Bacterial Peritonitis (2007) (0)
The maintenance of increased glucagon levels preclude the effects of somatostatin on splanchnic haemodynamics in portal hypertensive rats (1989) (0)
Osteoporosis and mineral metabolism disorders in liver transplant (OLT) patients (2006) (0)
Natriuretic hormone (NH) in the urine of patients with cirrhosis, and ascites (1989) (0)
P0019 : Adiponectin and related adipocytokines in steatotic and non-steatotic liver transplantation (2015) (0)
[Physiopathology and treatment of ascites in the cirrhotic patient]. (1987) (0)
[Infection by hepatitis virus in inmates and personnel of a penal institution]. (1985) (0)
[Cardiogenic shock in a 75-year-old man]. (1995) (0)
Vascular remodeling in cirrhosis: structural features and hemodynamic consequences (2002) (0)
Applicability of orthotopic liver transplantation (OLTx) in acute liver failure (ALF) (1990) (0)
メタドキシンは、アルコール患者の脂肪肝の回復を加速する:ランダム化二重盲検プラセボ対照試験の結果 (1998) (0)
p27Kip1 Is an independent predictor of recurrence after surgical resection of hepatocellular carcinoma (HCC) (2001) (0)
Circulating metalloproteinases and their tissue inhibitors in alcoholic liver disease. Relationship to liver fibrosis (1998) (0)
[Determination of arginine-vasopressin in small volumes of rat plasma]. (1986) (0)
[Can specialized medical training in Spain be improved?]. (2000) (0)
Vertical transmission of hepatitis delta virus (HDV) infection (1989) (0)
Hepatitis C. (2000) (0)
Nicardipine increases hepatic blood flow and the hepatic clearance of ICG in patients with cirrhosis (1990) (0)
Management problems in liver diseaseAscites (2007) (0)
Approaches to Protecting Steatotic Livers against Ischemia-Reperfusion Injury Insulin-Like Growth Factor and Epidermal Growth Factor Treatment: New (2009) (0)
Risk factors of cytomegalovirus cmv disease after liver transplantation lt (1992) (0)
Renal insensitivity to natriuretic hormone (NH) in conscious rats with cirrhosis and ascites (1991) (0)
Increased apoptosis in polymorphonuclear leukocytes from patients with cirrhosis and ascites (2003) (0)
1256 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORg IS INVOLVED IN THE BENEFITS OF RETINOL IN STEATOTIC AND NON-STEATOTIC LIVERS UNDERGOING PARTIAL HEPATECTOMY UNDER ISCHEMIA–REPERFUSION (2013) (0)
Study of HBV and HDV replication in HBsAg positive fulminant hepatitis (1989) (0)
Effects of propranolol on gastric microcirculation in cirrhotics with portal hypertensive gastropathy (1991) (0)
Prognostic value of hepatic clearance of indocyanine green (ICG) in cirrhotic patients who have bled from oesophageal varices (1989) (0)
The treatment of viral hepatitis, present and future. (2003) (0)
[Class I and II histocompatibility antigens and severity of the alcoholic liver lesion]. (1997) (0)
The role of metalloproteinases in CCl4 induced fibrosis. Influence of zinc administration (1998) (0)
Influence of abstinence on serum procollagen type III peptide levels in alcoholic liver disease (1989) (0)
Hepatocytes contribute to the increased hepatic production of cysteinyl leukotrienes in rats with cirrhosis (1998) (0)
Hepatobiliary Diseases. Pathophysiology and Imaging Professors Okuda, Mitchell, Itai and Ariyama, editors; Blackwell Science Ltd., Oxford 2001 (2002) (0)
[117] APELIN, A NOVEL NEUROENDOCRINE PEPTIDE, PLAYS AN IMPORTANT ROLE IN THE PATHOGENESIS OF THE CARDIOVASCULAR DYSFUNCTION IN CIRRHOSIS (2007) (0)
Predictive factors and outcome of hepatorenal syndrome in cirrhosis. Relevance of serum sodium concentration (2003) (0)
Evidence for a role of endothelium derived relaxing factor (EDRF) in the arterial hypotension and secondary sodium retention in cirrhosis (1991) (0)
Correspondence (2003) (0)
Hemodynamic effects of an acute increase in intra-abdominal pressure (IAP) in patients with cirrhosis (1991) (0)
Correspondence (2003) (0)
[Technics for the study of the renal excretion of free water in normal rats and those with experimental liver cirrhosis]. (1986) (0)
Survival and prognostic factors in patients with hepatocellular carcinoma. A multivariate analysis in 211 patients (1989) (0)
Textbook of Hepatology 3rd edition (2007) (0)
Blood levels of antioxidant vitamins in alcoholic liver disease. Relationship to liver damage (2003) (0)
564 TLR4 INDUCTION BY TUDCA IN EXPERIMENTAL MODELS OF SYNGENEIC AND ALLOGENEIC STEATOTIC LIVER TRANSPLANTATION (2013) (0)
Transcatheter arterial embolization (TAE) for hepatocellular carcinoma (HCC): Beneficial effects on portal pressure (1991) (0)
[Treatment of the syndrome of inappropriate antidiuretic hormone secretion with demethylchlortetracycline (author's transl)]. (1979) (0)
The splanchnic hyperemia of portal hypertension can be attenuated by increasing red blood cell volume. A nitric oxide related mechanism (1995) (0)
The effect of nutrition on alcoholic osteoporosis (2006) (0)
Liver and biliary Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis (2006) (0)
[Perception of the physicians regarding the scientific policy in health sciences in Spain]. (2011) (0)
Association between the histocompatibility antigens and the severity of alcoholic liver disease (1989) (0)
Session 8: Providing Scientific Evidence: RCTs and Beyond (2007) (0)
Does anti-HBc alone increase the risk for hepato-cellular carcinoma in anti-HCV positive cirrhosis? (1991) (0)
Spontaneous bacterial peritonitis (SBP) treated with cefotaxime: Predictive factors of infection resolution and patient survival (1991) (0)
Rifampicin versus phenobarbital for treatment of pruritus in primary biliary cirrhosis. Results of a crossover randomized trial (1990) (0)
Fibronectin plays a major role in the angiogenesis induced by ascites from cirrhotic patients (2003) (0)
P0014 : The effect of different nutritional support in liver surgery (2015) (0)
Decreasing incidence of hepatitis delta virus (HDV) infection (1991) (0)
Early ALT elevation is highly predictive of severe fibrosis and portal hypertension one year after liver transplantation in HCV-infected patients (2003) (0)
Active renin (AR) is better than plasma renin activity (PRA) for the assessment of the renin-angiotensin system (RAS) in cirrhosis with ascites (1990) (0)
A prognestic index (PI) for patient selection and timing of liver transplantation in cirrhosis with ascites (1991) (0)
Vitamin D deficiency and liver disease (2013) (0)
Chapter Forty – Ascites and spontaneous bacterial peritonitis (2006) (0)
Effects of the acute administration of a specific inducible nitric oxide synthase inhibitor (NOS) on splanchnic circulation in cirrhotic rats with ascites (2000) (0)
Letters to the editor (2005) (0)
18 Norepinephrine induces inflammatory actions and calcium mobilization in human hepatic stellate cells through alpha receptors (2004) (0)
The Effect of Liver Disease on the Urogenital Tract (2008) (0)
34 Anandamide is a powerful and selective vasodilator in the mesenteric resistance arteries of cirrhotic rats (2003) (0)
[199] VASCULAR ENDOTHELIAL GROWTH FACTOR TYPE A (VEGF-A) AND ANGIOPOIETIN-2 (ANG-2) ARE RELEVANT IN THE PATHOGENESIS OF THE INCREASED VASCULAR PERMEABILITY IN CIRRHOSIS (2007) (0)
[Scientific and technical advances in biomedicine: reflection on clinical management]. (2008) (0)
Sequence heterogeneity within ISDR and PePHD regions of HCV as marker of IFN response (2000) (0)
Aortic stenosis and ACE inhibitors (1998) (0)
Serum markers of fibrogenesis and collagenolysis in patients with chronic liver disease (1998) (0)
Anemia in primary biliary cirrhosis (PBC). A new prognostic feature (1991) (0)
Reduction of vascular compliance by propranolol influences the portal pressure response to pharmacological therapy (1998) (0)
TNF-α production induced by LPS endotoxin is augmented in rats with portal hypertension (1998) (0)
Influence of the genetic polymorphism of collagen type I A2 in the development of alcoholic cirrhosis (2001) (0)
Recurrence of variceal haemorrhage after chronic sclerotherapy. Comparison with the first variceal haemorrhage in cirrhotic patients (1991) (0)
Somatostatin (SMT) reduces urinary prostaglandin (PG) excretion and impairs renal function in cirrhosis with ascites (1991) (0)
Low bone mineral density in primary biliary cirrhosis. Influence of intestinal calcium absorption and bone formation (1989) (0)
ENDOGENOUS NITRIC OXIDE AND EXOGENOUS NITRIC OXIDE SUPPLEMENTATION IN HEPATIC ISCHEMIA-REPERFUSION INJURY IN THE RAT1 (2001) (0)
Resistin Prevents Visfatin Hepatic Recaptation from Adipose Tissue Inhepatic Surgery under Vascular Occlusion (2016) (0)
[Endotoxin and hepatic cirrhosis]. (1979) (0)
Human hepatic stellate cells express membrane proteins involved in antigen presentation and T-cell activation and internalize extracellular material (2003) (0)
Insulin and glucagon secretion in isolated pancreatic islets from rats with CCL4-induced cirrhosis (1989) (0)
Royal academy of medicine in Ireland international conference on homocysteine metabolism from basic science to clinical medicine (1995) (0)
Hemodynamic effects of albumin administration in spontaneous bacterial peritonitis (2002) (0)
Ritanserin decreases portal pressure (PP) in portal vein ligated and cirrhotic rats (1991) (0)
Increased vascular resistance to portal blood flow is the primary factor promoting portal hypertension in carbon tetrachloride cirrhotic rats (1985) (0)
Surgical resection improves survival in cirrhotics with asymptomatic hepatocellular carcinoma (1990) (0)
Hepatic transport processes (2007) (0)
[Spontaneous retroperitoneal hematoma as a complication of acute cholestatic viral hepatitis]. (1987) (0)
Lecture: Spontaneous Bacterial Peritonitis/Infections in Cirrhosis (2007) (0)
Esclerosi de varices esofàgiques (1985) (0)
Relationship between circulatory function and severity of renal failure in patients with cirrhosis and hepatorenal syndrome (2003) (0)
[A secure job for ever]. (2003) (0)
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17Sâ•’hydroxyâ•’DHA (2006) (0)
Prognostic value of records from continuous monitoring of intracranial pressure (ICP) in patients with acute liver failure (ALF) (1991) (0)
Fibrogenesis and collagenolysis in rats induced to liver cirrhosis (1989) (0)
[Organization and functioning model of biomedical research structures. Situation and future challenges]. (2008) (0)
Influence of the dynamics of HCV quasiespecies in the histologicaloutcome of liver transplantation (2000) (0)
A classic hepatology text Sheila Sherlock James Dooley (1997) (0)
Simultaneous hepatitis B and C following transfusion (1990) (0)
[Intracardiac thrombosis, bacterial endocarditis and pulmonary thromboembolism as a complication of peritoneovenous shunt]. (1987) (0)
Vitamin D receptor gene polymorphism and bone mass in primary biliary cirrhosis (1998) (0)
Non-invasive pulsed-doppler evaluation of the patency and blood flow in distal spleno-renal shunts. Comparisons with direct measurements at catheterization (1989) (0)
Antibodies to hepatitis C (anti_HCV) in postransfusion hepatitis (1990) (0)
Cerimònia d'investidura de doctors 'honoris causa' a Raimon Panikkar, Carmina Virgili i Joan Rodés (2008) (0)
[Hyperpotassemia as cause of death in hepatic cirrhosis]. (1974) (0)
Importance of the Cause of Renal Failure in Patients ith Cirrhosis (0)
VEGF and iNOS expression in human hepatocellular carcinoma (HCC) (2001) (0)
Age, obesity and hyperglycemia but not ethanol intake are the main risk factors for developing fatty liver in men (2000) (0)
Hepatitis C virus antibodies in chromic alcoholics: Association with the severity of liver injury (1990) (0)
Collagen-related markers of bone turnover reflect liver collagen metabolism in primary biliary cirrhosis (2006) (0)
[Deaths by a medical resident. Could they have been avoided?]. (2003) (0)
Recent advances in the treatment of ascites (1987) (0)
Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma. (1989) (0)
Value of bone alkaline phosphatase for assessing bone turnover in cholestatic liver disease. Comparison of two different methods (2006) (0)
Genetic evolution of hepatitis C virus after liver transplantation (2002) (0)
Intracellular calcium concentration ([Ca12+]) in vascular smooth muscle cells (VSMC) of cirrhotic rats. Effect of angiotensin II (AII) (1991) (0)
Virological and biochemical response to interferon administration are different in chronic hepatitis C (1998) (0)
HMGB1 in Steatotic and Non-Steatotic Liver Transplantation from brain- Dead Donors with Previous Ischemic Preconditioning (2016) (0)
[Coxiella burnetti pericarditis. An exceptional disease]. (1988) (0)
[Severe acute hepatitis as initial manifestation of chronic hepatitis B virus infection]. (1989) (0)
Primary biliary cirrhosis (1982) (0)
[Flumazenil for the assessment of the degree of hepatic encephalopathy]. (1991) (0)
Lack of effect of misoprostol, an orally active prostaglandin E1 analogue, and of I.V. prostaglandin E2 (PGE2) on renal function in patients with cirrhosis and ascites (1990) (0)
Effects of isosorbide-5-mononitrate (Is-5-Mn) on hepatic haemodynamics in cirrhotic rats (1990) (0)
Intractable Ascites Management: The Role of Side-to-Side Portacaval Shunt (1999) (0)
[Renal perfusion and the renin-angiotensin system in hepatic cirrhosis]. (1978) (0)
[Acute pseudotumoral alcoholic hepatitis]. (1973) (0)
[Determination of the concentration of gentamycin in the renal tissue of rats by radioimmunoassay]. (1984) (0)
[Is a low-sodium diet necessary in patients with ascites?]. (1985) (0)
Acute rejection in liver transplantation: Predictive factors of response to anti-rejection therapy (1991) (0)
Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis. (1994) (0)
Mineralocorticoid escape in compensated cirrhotics with portal hypertension. Relationship with natriuretic and antinatriuretic systems (1990) (0)
Hypersensitivity of monocytes from cirrhotic patients to endotoxin administration. Effects of lipoproteins and albumin (2002) (0)
145 THERAPEUTIC TARGETS IN LIVER TRANSPLANTATION: ANGIOTENSIN II IN NON-STEATOTIC GRAFTS AND ANGIOTENSIN-(1–7) IN STEATOTIC GRAFTS (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Juan Rodés?

Juan Rodés is affiliated with the following schools:

University of Barcelona